Growth inhibition of re-challenge B16 melanoma transplant by conjugates of melanogenesis substrate and magnetite nanoparticles as the basis for developing melanoma-targeted chemo-thermo-immunotherapy

Journal of Biomedicine and Biotechnology

Volumn 2009, Issue , 2009, Pages

  Jimbow, Kowichi ^a,e   Takada, Tomoaki ^a   Yamashita, Toshiharu ^a   Sato, Makito ^a   Sato, Akiko ^a   Ono, Ichiro ^a   Tamura, Yasuaki ^a   Sato, Noriyuki ^a   Miyamoto, Atsushi ^a   Ito, Akira ^b   Honda, Hiroyuki ^c   Wakamatsu, Kazumasa ^d   Ito, Shosuke ^d  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

^d FUJITA HEALTH UNIVERSITY   (Japan)

^e Institute of Dermatology and Cutaneous Sciences   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 70; MAGNETITE; NANOPARTICLE; PROPIONYLCYSTEAMINYLPHENOL; UNCLASSIFIED DRUG; CYSTAMINE; DRUG DERIVATIVE; FREE RADICAL; N PROPIONYL 4 S CYSTEAMINYLPHENOL; N-PROPIONYL-4-S-CYSTEAMINYLPHENOL; PHENOL DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRAFT; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CD8+ T LYMPHOCYTE; CONJUGATION; CONTROLLED STUDY; FEMALE; HEAT; HYPERTHERMIC THERAPY; LIFESPAN; MAGNETIC FIELD; MELANOMA; MOUSE; NONHUMAN; TEMPERATURE MEASUREMENT; THERAPY EFFECT; TREATMENT DURATION; TUMOR GROWTH; ANIMAL; CANCER TRANSPLANTATION; EXPERIMENTAL NEOPLASM; IMMUNOTHERAPY; METABOLISM; TIME;

MUS;

ANIMALS; CYSTAMINE; FEMALE; FERROSOFERRIC OXIDE; FREE RADICALS; HOT TEMPERATURE; IMMUNOTHERAPY; MELANOMA; MICE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PHENOLS; TIME FACTORS;

EID: 71149086160     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2009/457936     Document Type: Article

References (34)

1. Jimbow K., Iwashina T., Alena F., Yamada K., Pankovich J., Umemura T., Exploitation of pigment biosynthesis pathway as a selective chemotherapeutic approach for malignant melanoma The Journal of Investigative Dermatology 1993 100 supplement 2 231S 238S
2. Alena F., Iwashina T., Gili A., Jimbow K., Selective in vivo accumulation of N-acetyl-4-S-cysteaminylphenol in B16F10 murine melanoma and enhancement of its in vitro and in vivo antimelanoma effect by combination of buthionine sulfoximine Cancer Research 1994 54 10 2661 2666
3. Pankovich J. M., Jimbow K., Tyrosine transport in a human melanoma cell line as a basis for selective transport of cytotoxic analogues Biochemical Journal 1991 280 3 721 725
4. Reszka K., Jimbow K., Fuchs J., Packer L., Electron donor and acceptor properties of melanin pigments in the skin Oxidative Stress in Dermatology, J. Fuchs and L. Packer, Eds., pp. 287 320, Marcel Dekker, New York, NY, USA, 1993
5. Tandon M., Thomas P. D., Shokravi M., Synthesis and antitumour effect of the melanogenesis-based antimelanoma agent N-Propionyl-4-S-cysteaminylphenol Biochemical Pharmacology 1998 55 12 2023 2029
6. Thomas P. D., Kishi H., Cao H., Selective incorporation and specific cytocidal effect as the cellular basis for the antimelanoma action of sulphur containing tyrosine analogs The Journal of Investigative Dermatology 1999 113 6 928 934
7. Algan O., Fosmire H., Hynynen K., External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma Cancer 2000 89 2 399 403
8. Hurwitz M. D., Kaplan I. D., Hansen J. L., Association of rectal toxicity with thermal dose parameters in treatment of locally advanced prostate cancer with radiation and hyperthermia International Journal of Radiation Oncology, Biology, Physics 2002 53 4 913 918
9. Johannsen M., Gneveckow U., Eckelt L., Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique International Journal of Hyperthermia 2005 21 7 637 647
10. Kawai N., Ito A., Nakahara Y., Anticancer effect of hyperthermia on prostate cancer mediated by magnetite cationic liposomes and immune-response induction in transplanted syngeneic rats Prostate 2005 64 4 373 381
11. Lindquist S., The heat-shock response Annual Review of Biochemistry 1986 55 1151 1191
12. Konno A., Sato N., Yagihashi A., Heat- or stress-inducible transformation-associated cell surface antigen on the activated H-ras oncogene-transfected rat fibroblast Cancer Research 1989 49 23 6578 6582
13. Mnoret A., Chandawarkar R., Heat-shock protein-based anticancer immunotherapy: an idea whose time has come Seminars in Oncology 1998 25 6 654 660
14. Srivastava P. K., Mnoret A., Basu S., Binder R., Quade K., Heat shock proteins come of age: primitive functions acquired new roles in an adaptive world Immunity 1998 8 6 657 665
15. Tamura Y., Tsuboi N., Sato N., Kikuchi K., 70kDa heat shock cognate protein is a transformation-associated antigen and a possible target for the hosts anti-tumor immunity The Journal of Immunology 1993 151 10 5516 5524
16. Tamura Y., Peng P., Liu K., Daou M., Srivastava P. K., Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations Science 1997 278 5335 117 120
17. Mosser D. D., Caron A. W., Bourget L., Denis-Larose C., Massie B., Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis Molecular and Cellular Biology 1997 17 9 5317 5327
18. Tamura Y., Sato N., Heat shock proteins: chaperoning of innate and adaptive immunities Japanese Journal of Hyperthermic Oncology 2003 19 131 139
19. Srivastava P. K., Immunotherapy for human cancer using heat shock protein-peptide complexes Current Oncology Reports 2005 7 2 104 108
20. -, TCR-αβ-killer T cells The Journal of Immunology 1996 157 8 3391 3395
21. Yanase M., Shinkai M., Honda H., Wakabayashi T., Yoshida J., Kobayashi T., Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes Japanese Journal of Cancer Research 1998 89 7 775 782 (Pubitemid 28401164)
22. Ueda G., Tamura Y., Hirai I., Tumor-derived heat shock protein 70-pulsed dendritic cells elicit-tumor-specific cytotoxic T lymphocytes (CTLs) and tumor immunity Cancer Science 2004 95 3 248 253
23. Ito A., Honda H., Kobayashi T., Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of heat-controlled necrosis with heat shock protein expression Cancer Immunology, Immunotherapy 2006 55 3 320 328
24. Shi H., Cao T., Connolly J. E., Hyperthermia enhances CTL cross-priming The Journal of Immunology 2006 176 4 2134 2141
25. Ito A., Fujioka M., Yoshida T., 4-S-cysteaminylphenol-loaded magnetite cationic liposomes for combination therapy of hyperthermia with chemotherapy against malignant melanoma Cancer Science 2007 98 3 424 430
26. Sato M., Yamashita T., Ohkura M., N-propionyl-cysteaminylphenol-magnetite conjugate (NPrCAP/M) is a nanoparticle for the targeted growth suppression of melanoma cells The Journal of Investigative Dermatology 2009 129 9 2233 2241
27. Brozyna A. A., VanMiddlesworth L., Slominski A. T., Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy International Journal of Cancer 2008 123 6 1448 1456
28. Slominski A., Zbytek B., Slominski R., Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells International Journal of Cancer 2009 124 6 1470 1477
29. Suzuki M., Shinkai M., Honda H., Kobayashi T., Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes Melanoma Research 2003 13 2 129 135
30. Ito A., Shinkai M., Honda H., Wakabayashi T., Yoshida J., Kobayashi T., Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia Cancer Immunology, Immunotherapy 2001 50 10 515 522
31. Jimbow K., Takada T., Sato M., Melanin biology and translational research strategy; melanogenesis and nanomedicine as the basis for melanoma-targeted DDS and chemothermo-immunotherapy Pigment Cell and Melanoma Research 2008 21 2 243
32. Jimbow K., Miyake Y., Homma K., Characterization of melanogenesis and morphogenesis of melanosomes by physicochemical properties of melanin and melanosomes in malignant melanoma Cancer Research 1984 44 3 1128 1134
33. Minamitsuji Y., Toyofuku K., Sugiyama S., Jimbow K., Sulphur containing tyrosinase analogs can cause selective melanocytoxicity involving tyrosinase-mediated apoptosis The Journal of Investigative Dermatology 1999 4 2 130S 136S
34. Osai Y., Ohkura M., Tamura Y., Intratumoral administration of melanoma targeting N-propionyl cysteaminylphenol induces in vivo anti-melanoma effect and tumor specific immunity Pigment Cell Melanoma Research 2008 21 2 329